Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Enterprise Value (2018 - 2026)

Equillium (EQ) posted quarterly Enterprise Value of -$61.3 million for Q1 2026, down 322.91% year-over-year from $27.5 million in Q1 2025, and down 106.24% quarter-over-quarter from -$29.7 million in Q4 2025.

Analysis

Equillium (EQ) Enterprise Value (2018 - 2026) Analysis & Trends

Equillium (EQ) has reported Enterprise Value for 10 consecutive years, with -$61.3 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Enterprise Value fell 322.91% year-over-year to -$61.3 million; the TTM figure through Mar 2026 stood at -$61.3 million (down 322.91% YoY), while the FY2025 annual figure was -$29.7 million, down 31.71% from the prior year.
  • Enterprise Value retreated to -$61.3 million in Q1 2026 per EQ's latest filing, from -$29.7 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$10.3 million in Q2 2025 and bottomed at -$71.0 million in Q4 2022.
  • Historically, Enterprise Value has averaged -$41.3 million across 5 years, with a median of -$40.9 million in 2023.
  • Annual changes were most pronounced in 2025 — Enterprise Value surged 69.17% — and 2026, when it tumbled 322.91%.
  • Equillium's Enterprise Value stood at -$71.0 million in 2022, then soared by 42.46% to -$40.9 million in 2023, then surged by 44.76% to -$22.6 million in 2024, then plunged by 31.71% to -$29.7 million in 2025, then sank by 106.24% to -$61.3 million in 2026.
  • Business Quant data shows EQ's Enterprise Value at -$61.3 million in Q1 2026, -$29.7 million in Q4 2025, and -$33.1 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Equillium 249.33 Mn 249.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300.58 Mn
Mar 31, 2026 131.24 Mn
Dec 31, 2025 64.99 Mn
Sep 30, 2025 53.65 Mn
Jun 30, 2025 -241,271.25
Mar 31, 2025 -489,311.59
Dec 31, 2024 3.17 Mn
Sep 30, 2024 3.60 Mn
Jun 30, 2024 -8.74 Mn
Mar 31, 2024 49.15 Mn
Dec 31, 2023 -15.38 Mn
Sep 30, 2023 -20.32 Mn
Jun 30, 2023 -22.45 Mn
Mar 31, 2023 -36.87 Mn
Dec 31, 2022 -34.54 Mn
Sep 30, 2022 31.74 Mn
Jun 30, 2022 12.52 Mn
Mar 31, 2022 39.15 Mn
Dec 31, 2021 30.34 Mn
Sep 30, 2021 109.70 Mn